Ichihara, Japan

Yoshitaka Waga

This inventor holds 1 USPTO granted patent. Top assignee: Prime Polymer Co., Ltd.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshitaka Waga

Introduction

Yoshitaka Waga is a notable inventor based in Ichihara, Japan. He has made significant contributions to the field of medical materials through his innovative patent. His work focuses on enhancing the quality and functionality of medical products.

Latest Patents

Waga holds a patent for an injection-molded article for medical use. This invention utilizes a medical propylene-ethylene-based resin composition, which includes a specific blend of propylene-ethylene copolymers and elastomers. The patent emphasizes the importance of material properties, such as melt flow rate and density, to ensure the effectiveness of medical applications.

Career Highlights

Yoshitaka Waga is associated with Prime Polymer Co., Ltd., where he has been instrumental in developing advanced materials for medical use. His expertise in polymer science has led to innovative solutions that meet the stringent requirements of the healthcare industry. Waga's dedication to research and development has positioned him as a key figure in his field.

Collaborations

Waga collaborates with talented colleagues, including Yuya Tanaka and Nagisa Endo. Together, they work on various projects aimed at improving medical materials and applications. Their combined efforts contribute to the advancement of technology in the medical sector.

Conclusion

Yoshitaka Waga's contributions to the field of medical materials through his innovative patent demonstrate his commitment to enhancing healthcare solutions. His work continues to impact the industry positively, showcasing the importance of innovation in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…